Victrex plc (LON:VCT) shares hit a new 52-week high on Tuesday . The stock traded as high as GBX 3,434 ($44.73) and last traded at GBX 3,408 ($44.39), with a volume of 245566 shares. The stock had previously closed at GBX 3,396 ($44.24).
VCT has been the topic of several recent analyst reports. Peel Hunt restated an “add” rating on shares of Victrex in a research report on Wednesday, July 25th. Liberum Capital restated a “buy” rating and set a GBX 2,825 ($36.80) target price on shares of Victrex in a research report on Wednesday, July 25th. Morgan Stanley upped their target price on shares of Victrex from GBX 1,600 ($20.84) to GBX 2,980 ($38.82) and gave the stock an “equal weight” rating in a research report on Monday, July 16th. Citigroup restated a “neutral” rating on shares of Victrex in a research report on Tuesday, July 17th. Finally, Barclays restated an “underweight” rating and set a GBX 2,380 ($31.00) target price (up from GBX 2,300 ($29.96)) on shares of Victrex in a research report on Tuesday, July 24th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of GBX 2,524.50 ($32.88).
In other Victrex news, insider Jakob Sigurdsson purchased 3,250 shares of Victrex stock in a transaction on Wednesday, July 25th. The shares were bought at an average price of GBX 3,072 ($40.02) per share, with a total value of £99,840 ($130,050.80). Insiders acquired 3,262 shares of company stock worth $10,021,700 in the last ninety days.
Victrex Company Profile (LON:VCT)
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Further Reading: What is a closed-end mutual fund (CEF)?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.